The relationship of lactate dehydrogenase, pH, glucose and protein pleural fluids with one year life of patients with non-small cell lung carcinoma with malignant pleural effusion in Prof. Dr IGNG Ngoerah Denpasar
Keywords:
Pleural effusion, LDH, pH, Protein, Glucose, SurvivalAbstract
Malignant pleural effusion (MPE) is one of the most common metastases in Non-Small Cell Lung Carcinoma (NSCLC). Some part of the pleural fluid analysis affects the patient's survival. A retrospective cohort study using medical record data of 76 patients was done in Prof. Dr. IGNG Ngoerah General Hospital. The one-year survival was 36.6%, with a median survival of 240 days or 8 months (95% CI 110.94–369.05). The cut-off point for pleural fluid protein was 5 g/dL (sensitivity 33.3%, specificity 32.1%), glucose 47.5 mg/dL (sensitivity 81.3%, specificity 32.1%), lactate dehydrogenase (LDH) 978.5 IU/L (sensitivity 41.7%, specificity 46.4%) and pH 7.3 (sensitivity 62.5%, specificity 35.7%). Bivariate analysis showed that only protein was associated with survival. Protein < 5 g/dL had a median survival of 116 days (95% CI 67.96 – 164.05, p = 0.001). Multivariate analysis showed pleural fluid protein < 5gr dL, best supportive care therapy, and non-adenocarcinoma histology were independent risk factors for death {HR 2,345,95% CI: 1,055-5,214; p= 0.037; HR 5,332. 95% CI: 2.109 – 13.478; p = 0.000; HR 2,635, 95% CI 1,096 – 6,335; p = 0.30).
Downloads
References
Abrao FC, Abreu IRLBd, Fogarolli M, Caxeiro G, Bezerra CBS, Cesar FPdC, et al. 2015. Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion. Annals of Surgical Oncology; 22(4): 083-8.
Akhtar N and Bansa JP. 2017. Risk factors of Lung Cancer in Non-smoker Risk Factors of Lung Cancer. Current Problems in Cancer.
Batra H and Antony VB. 2015 Pleural Mesothelial Cells in Pleural and Lung Diseases.Journal of Thoracic Disease;7(6):964-980
Beril, GK, Macit, C., Kadioglu, SB, Salepci, T., Clark, PM, 2013. Quality of Life Assessment of Patients with Metastatic Lung Cancer Receiving Platinum-Based Chemotherapy. Marmara Pharmaceutical Journal; 17(10):120–130.
Bielsa S, Salud A, Martínez M, Esquerda A, Martín A, Rodríguez-Panadero F, et al. 2008. Prognostic significance of pleural fluid data in patients with malignant effusion. European Journal of Internal Medicine; 19:334-9.
Burrows CM, Matheus WC, Colt HG. 2000. Predicting Survival in Patients With Recurrent Symptomatic Malignant Pleural Effusions.CHEST; 117:73–78.
Consonni D, De MS, Lubin JH, et al. 2010. Lung Cancer and Occupation in a Population-Based Case-Control Study. Am J Epidemiol; 171:323-33.
Edwards SL. Pathophysiology of acid-base balance: The theory-practice relationship. Intensive and Critical Care Nursing; 24:28-40.
Ekaruna IB, Rai IB, Suryana IK. 2021. “Relationship Between Anemia, Hypoalbuminemia, and Vitamin D Deficiency with the Quality of Life of Lung Cancer Patients with Advanced Stage Non-Small Cell Carcinoma at Prof. Hospital. Dr. IGNG Ngoerah” (thesis). Denpasar: Udayana University.
Ellis R, Priff N. 1994. Chemotherapy and Cancer Treatment. In : Chemotherapy handbook. Spring House, Pennsylvania; 1-41.
Fawziah, A. 2014. “One Year Survival of Patients with Non-Small Lung Carcinoma Stage IIIb/IV Elderly Cells Undergoing Chemotherapy Compared With Non-Chemotherapy (thesis). Jakarta: University of Indonesia FK.
Febriani A and Furqon A. Lung Cancer Metastases. 2018. Journal of Respiration (JR); 4(3): 94-101.
Fitzgerald DB, Leong SL, Budgeon CA. et al. 2019.Relationship of Pleural Fluid pH and Glucose: A Multi-Centre Study of 2,971 Cases. Journal of Thoracic Disease.;11(1):123-130
Good Jr, Daryle DA, Sahn SA. 2005. The Pathogenesis of Low Glucose, Low pH Malignant Effusion. Am Rev Respir At ;131(5):737-41.
Goodman MT and Wilkens LR. 1992. Relation of body size and the risk of lung cancer.Nutrition and cancer; 20:2, 179-186.
Hasanah FK and Helma. 2019. Factors Affecting Increased Blood Sugar Levels in Patients at the Fanisa Clinic, Pariaman City with Using Factor Analysis.UN Pjo Math; 2(3).
Heffner JE, Paul JN, and Celia B. 2000. Pleural fluid PH as a predictor of pleurodesis failure. Chests ;117: 87–95.
Heffner J.E. 2008. Diagnosis and management of malignant pleural effusions. Respirology 2008;1:5-20.
Hendro I, Nusjirwan R, Hapsari P. 2019. Factors predicting 30-day mortality in patients with malignant pleural effusion who have had chest tube thoracostomy at RSUP DR. Hassan Sadikin. J Indonesian Surgery; 47(1).
Jusuf A. 2019 Treatment of Lung Cancer in the Thoracic Oncology Textbook Series. Department of Pulmonology and Respiratory Medicine FKUI Jakarta.
Kasapoglu US, Arinc S, Gungor S, Irmak I. 2016. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions. The Clinical Respiratory Journal.
Kreuzer M, Kreienbrock L, Gerken M, et al. 1998. Risk Factors for Lung Cancer in Young Adults.Am J Epidemiol; 147(11).
Magy Satolom, Nunuk Sri Muktiati, Ngakan Putu Parsama Putra, Asri Maharani. 2012. Characteristics of Vascular Endothelial Growth Factor, Glucose, Lactate Dehydrogenase and Protein in Non-Malignant Pleural Effusion and Malignant Pleural Effusion. J Respir Indo; 32(3).
Myrnasari RS, Astuti T, Pratiwi SD,Pulmonology D, Faculty R, University K.2017. Preliminary Study: Profile of Increased PAI-1 Levels in Lung Cancer Patients Receiving Chemotherapy Preliminary Study:
Increased Profile of PAI-1 in Lung Cancer Patients Receiving Chemotherapy; 38(1):48-56.
NCCN. 2019. Non-Small Cell Lung Cancer, NCCN Clinical Practice Guidelines in Oncology; 3(2019): 1–225.
Neuberger JS and Field RW. 2003. Occupation and Lung Cancer in Nonsmokers. Reviews on Environmental Health; 18(4).
Pantazopoulos I, Xanthos T, Vlachos I, Kakoulas Z, Stroumpoulis K, Chalkias A,
et al. 2014. Pleural Fluid Glucose: A Predictor of Unsuccessful Pleurodesisin a Preselected Cohort of Patients with Malignant Pleural Effusion. Jbuon; 19(4):1018-1023.
Porcel JM., Azzopardi M., Koegelenberg CF., Maldonado F. The Diagnosis of Pleural Effusions. 2015. Expert Rev. Respire. medical; 00(00): 1–15.
Rahman NM, Mishra EK, Davies HE, et al. 2008. Clinically Important Factors Influencing the Diagnostic Measurement of Pleural Fluid pH and Glucose. Am J Respir Crit Care Med; 178:483-90.
Ramadhaniah F, Mulawarman A, Suzanna E, Andalucia LR. 2016. Overview of Non-Small Cell Carcinoma Lung Cancerwith pleural effusion. J Respir Indo; 36(2).
Rodriguez BA andFuentes JM. Lung cancer in women. 2012. Lung Cancer: Targets and Therapy;:3 79–89.
Shojaee S, Singh I, Solsky I, Nana-Sinkam P. Malignant pleural effusion at presentation in patients with small-cell lung cancer. Respiration. 2019;98(3):198-202.
Steven AS, John E. Heffner. Pleural fluid analysis. In: Light R, Lee GY, eds. Textbook of Pleural Effusions Disease. London: Hodder Arnold; 209–26.
Sugiarta AA. 2019. The Impact of Noise and Air Quality on Environmental Preservation in the City of Denpasar (thesis). Denpasar: Udayana University.
Supartono and Suryanto A. 2012. Factors Affecting One-Year Survival of Patients with Advanced Stage Lung Cancer at RSUP Dr. Kariadi Semarang. Medica Hospitalia;1 (1).
Verma A, Phua C, Sim WY, Algoso W. et al. 2016. Pleural LDH as a Prognostic Marker in Adenocarcinoma Lung with Malignant Pleural Effusion. medicine; 95:26.
Verma A, Phua CK, Yua SW. et al. 2016. Pleural LDH as a Prognostic Marker in Adenocarcinoma Lung with Malignant Pleural Effusion, Medicine, 95 (26).
Xu Z, Yabg Q, Chen X, et al. 2019. Clinical Association and Prognostic Value of Site-Specific Metastases in NSCLC: A Population-Based Study. Oncology Letters; 17:5590-5600.
Zaini Jamal, Syahruddin Elisna. 2018. Lung Cancer Is Not Small Cell. In: Rasmin, M., Jusuf, A., Yunus, F. Amin, M., Rai, N., editor. Textbook of Pulmonology and Respiratory Medicine. Edition 1. Jakarta: UI Publishing.pp.9-23
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
